PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
02-Feb-2023 Pneuma Respiratory Announces a Novel Platform That Could Revolutionize Smoking Cessation Therapies and Reduced-Risk Nicotine Products Businesswire
02-Feb-2023 America's Frontier Fund Launches Strategic Innovation Group to Support Fund's Mission of Advancing Frontier Technologies in America Businesswire
02-Feb-2023 Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Invivyd, Inc. f/k/a Adagio Therapeutics, Inc. (IVVD) on Behalf of Investors Businesswire
02-Feb-2023 Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of National Vision Holdings, Inc. (EYE) on Behalf of Investors Businesswire
02-Feb-2023 Takeda, que repite sólidos resultados en el tercer trimestre del año fiscal 2022, reafirma su crecimiento a largo plazo con el avance de su cartera de productos en desarrollo y dos adquisiciones selectivas Businesswire
02-Feb-2023 Takeda reforça o crescimento de longo prazo por meio do avanço do seu portfólio e duas aquisições específicas, com um terceiro trimestre forte no ano fiscal de 2022 Businesswire
02-Feb-2023 European Authorities Approve Lyophilized S/D Treated Plasma OctaplasLG® for Pre-Hospital Transfusion Businesswire
02-Feb-2023 Accenture Expands Strategy Capabilities in Life Sciences with the Acquisition of Bionest Businesswire
02-Feb-2023 Applied DNA to Report First Quarter Fiscal 2023 Financial Results and Host Investor Conference Call and Webcast on Thursday, February 9, 2023 Businesswire
02-Feb-2023 First Alberta Clinical Site for Study of Psychedelic-Assisted Treatment for Alcohol Use Disorder Approved Businesswire
02-Feb-2023 Takeda stärkt langfristiges Wachstum durch Fortschritte in der Pipeline und zwei gezielte Akquisitionen; erneut ein starkes drittes Quartal im GJ2022 Businesswire
02-Feb-2023 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
02-Feb-2023 Know Labs Provides Update on Strategic Partners Engaged in Data Science, Product Engineering and Regulatory Affairs to Accelerate Progress Toward FDA Application Businesswire
02-Feb-2023 Vistagen Announces Closing of Pherin Pharmaceuticals Acquisition Businesswire
02-Feb-2023 Life Science Connect Drives 5x Revenue Growth with ON24 Businesswire
02-Feb-2023 Coya Therapeutics, Inc. to Present Proof of Concept Clinical Data at Multiple Scientific Conferences Throughout 2023 Businesswire
02-Feb-2023 PharmaCyte Biotech to Implement Second $10-Million Share Repurchase Plan Businesswire
02-Feb-2023 OM1 Launches Analytic Reports Uncovering Causes of Medication Discontinuation in Immunology Patients Businesswire
02-Feb-2023 RefleXion Receives FDA Clearance for SCINTIX Biology-Guided Radiotherapy; Cutting-edge Treatment Applicable for Early and Late-stage Cancers Businesswire
02-Feb-2023 Former FDA Senior Officials Join Greenleaf Health: Sandra Kweder, M.D., former Deputy Director of FDA’s Office of New Drugs & Donald D. Ashley, J.D., former Director of CDER’s Office of Compliance Businesswire